Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.390NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.572NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.397NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.3 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.523NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.116 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.38 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.340NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.437NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.452NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.400NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.16 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.37 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.336NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.317NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
BQ.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used